Jounce Therapeutics Announces Results from Pre-Planned Data Review of INNATE Phase 2 Trial of JTX-8064 and Pimivalimab Demonstrating Deep and Durable Responses in Platinum Resistant Ovarian Cancer
Ovarian Combination Cohort Target Lesion % Change from Baseline over Time Ovarian Combination Cohort Target…
IronSight AI and Fast Iron Partner to Bring AI-Powered Inventory Capture to Caterpillar, Komatsu and Volvo Equipment Dealers
WCDPQ Plans South American Expansion in 2027, Including 30 New Positions